Aritcle Type: Case Report
Citation: Zambelis T, Zouvelou V, Karandreas N (2015) Complete Remission of Lambert-Eaton Myasthenic Syndrome after Successful Treatment of Small-Cell Lung Cancer. Autoimmun Infec Dis 1 (1): doi http://dx.doi.org/10.16966/aidoa.105
Copyright: © 2015 Zambelis T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Publication history:
Authors :
Thomas Zambelis* Vassiliki Zouvelou Nikolaos Karandreas
Department of Neurology, University of Athens, Aeghinition Hospital, EMG laboratory,Athens, Greece.
*Corresponding author: Thomas Zambelis, Aeghinition Hospital. 74, Vass. Sofias Ave. 11528Athens, Greece, Tel: +30210-7250410; E-mail: tzabelis@med.uoa.gr

Figure 1. A. RNS in ADM at diagnosis. B=Compound muscular action potential (CMAP) from ADM at rest and after 10sec of muscular contraction at diagnosis. C= RNS in ADM after cancer treatment. D= CMAP from ADM after cancer treatment. ADM=Abductor digiti minimi, RNS= Repetitive nerve stimulation

Figure 1. A. RNS in ADM at diagnosis. B=Compound muscular action potential (CMAP) from ADM at rest and after 10sec of muscular contraction at diagnosis. C= RNS in ADM after cancer treatment. D= CMAP from ADM after cancer treatment. ADM=Abductor digiti minimi, RNS= Repetitive nerve stimulation
No comments:
Post a Comment